Technical note: Linkage disequilibrium and disease-associated CTLA4 gene polymorphisms

被引:51
作者
Holopainen, PM [1 ]
Partanen, JA [1 ]
机构
[1] Finnish Red Cross Blood Transfus Serv, Dept Tissue Typing, Helsinki 00310, Finland
关键词
D O I
10.4049/jimmunol.167.5.2457
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CTLA4 and CD28 are important regulators of T lymphocyte activation. Gene region 2q33 carrying genes for both CTLA4 and CD28 has been shown to be linked to many autoimmune diseases. Disease associations with particular CTLA4 gene polymorphisms have been reported. Recently, first lines of evidence emerged for functional effects of CTLA4 gene polymorphisms. Two independent studies reported a reduced inhibitory function of CTLA4 in individuals with certain CTLA4 genotypes: those with a high number of microsatellite repeats in one study and those with allele +49*G in exon 1 in the other one. We analyzed the strength of linkage disequilibrium between the three known CTLA4 polymorphisms among 577 independent chromosomes. Our results show that the polymorphisms previously suggested to be the functional risk factors nearly always occur together in a very frequent haplotype. Due to this strong linkage disequilibrium, we conclude that the previous reports studying merely a single polymorphism could not distinguish which variation actually caused the functional difference. Hence, either mutagenesis approaches or studies with data on all linked polymorphisms are still needed to determine the genuine functional risk polymorphism in this gene region.
引用
收藏
页码:2457 / 2458
页数:2
相关论文
共 18 条
  • [1] CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis
    Braun, J
    Donner, H
    Siegmund, T
    Walfish, PG
    Usadel, KH
    Badenhoop, K
    [J]. TISSUE ANTIGENS, 1998, 51 (05): : 563 - 566
  • [2] An Mse I RFLP in the human CTLA4 promotor
    Deichmann, K
    Heinzmann, A
    Bruggenolte, E
    Forster, J
    Kuehr, J
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 225 (03) : 817 - 818
  • [3] CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus
    Donner, H
    Rau, H
    Walfish, PG
    Braun, J
    Siegmund, T
    Finke, R
    Herwig, J
    Usadel, KH
    Badenhoop, K
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (01) : 143 - 146
  • [4] CTLA4 gene haplotypes cannot protect from IDDM in the presence of high-risk HLA DQ8 or DQ2 alleles in German families
    Donner, H
    Seidl, C
    Braun, J
    Siegmund, T
    Herwig, J
    Seifried, E
    Usadel, KH
    Badenhoop, K
    [J]. DIABETES, 1998, 47 (07) : 1158 - 1160
  • [5] Eaves IA, 2000, NAT GENET, V25, P320
  • [6] Harbo HF, 1999, TISSUE ANTIGENS, V53, P106
  • [7] The development of Graves' disease and the CTLA-4 gene on chromosome 2q33
    Heward, JM
    Allahabadia, A
    Armitage, M
    Hattersley, A
    Dodson, PM
    MacLeod, K
    Carr-Smith, J
    Daykin, J
    Daly, A
    Sheppard, MC
    Holder, RL
    Barnett, AH
    Franklyn, JA
    Gough, SCL
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (07) : 2398 - 2401
  • [8] CD28/CTLA4 gene region on chromosome 2q33 confers genetic susceptibility to celiac disease.: A linkage and family-based association study
    Holopainen, P
    Arvas, M
    Sistonen, P
    Mustalahti, K
    Collin, P
    Mäki, M
    Partanen, J
    [J]. TISSUE ANTIGENS, 1999, 53 (05): : 470 - 475
  • [9] Genetic association of Ctla-4 to myasthenia gravis with thymoma
    Huang, D
    Li, L
    Norén, K
    Xia, SQ
    Trifunovic, J
    Pirskanen, R
    Lefvert, AK
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1998, 88 (1-2) : 192 - 198
  • [10] Dinucleotide repeat expansion in the CTLA-4 gene leads to T cell hyper-reactivity via the CD28 pathway in myasthenia gravis
    Huang, DR
    Giscombe, R
    Zhou, YH
    Pirskanen, R
    Lefvert, AK
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2000, 105 (01) : 69 - 77